Meisinger Christa, Baumert Jens, Khuseyinova Natalie, Loewel Hannelore, Koenig Wolfgang
GSF The National Research Center for Environment and Health, Institute of Epidemiology, Neuherberg, Germany.
Circulation. 2005 Aug 2;112(5):651-7. doi: 10.1161/CIRCULATIONAHA.104.529297. Epub 2005 Jul 25.
Oxidized LDL (oxLDL) is thought to play a key role in the inflammatory response in the arterial vessel wall.
In a prospective, nested, case-control study, the association between plasma oxLDL and risk of an acute coronary heart disease (CHD) event was investigated in men without prevalent CHD or diabetes mellitus at baseline. Subjects came from 2 population-based MONICA/KORA Augsburg surveys conducted in the years 1989-1990 and 1994-1995 with follow-up in 1998 (mean+/-SD follow-up time, 5.6+/-2.6 years). OxLDL was determined by ELISA in 88 men with incident CHD and in 258 age- and survey-matched controls. Hazard ratios (HRs) were estimated from conditional logistic-regression models with matching for age and survey. Baseline mean plasma oxLDL concentrations were significantly higher in subjects who subsequently experienced an event compared with controls (mean+/-SD, 110+/-32 versus 93+/-28 U/L; P< or =0.001). After adjustment for smoking, hypertension, obesity, physical activity, education, and alcohol consumption, the HR for a future CHD event in a comparison of the upper tertile of the oxLDL distribution with the lower tertile was 4.25 (95% confidence interval, 2.09 to 8.63; P<0.001). Plasma oxLDL was the strongest predictor of CHD events compared with a conventional lipoprotein profile and other traditional risk factors for CHD. When both oxLDL and C-reactive protein were simultaneously assessed in the same model, they still predicted future CHD events even after multivariable adjustment.
Elevated concentrations of oxLDL are predictive of future CHD events in apparently healthy men. Thus, oxLDL may represent a promising risk marker for clinical CHD complications and should be evaluated in further studies.
氧化型低密度脂蛋白(oxLDL)被认为在动脉血管壁的炎症反应中起关键作用。
在一项前瞻性、嵌套式病例对照研究中,对基线时无冠心病或糖尿病的男性,研究了血浆oxLDL与急性冠心病(CHD)事件风险之间的关联。受试者来自1989 - 1990年和1994 - 1995年进行的两项基于人群的奥格斯堡MONICA/KORA调查,并于1998年进行随访(平均±标准差随访时间,5.6±2.6年)。通过酶联免疫吸附测定法(ELISA)测定了88例冠心病发病男性和258例年龄及调查匹配的对照者的oxLDL。采用条件逻辑回归模型,对年龄和调查进行匹配,估计风险比(HRs)。与对照组相比,随后发生事件的受试者基线平均血浆oxLDL浓度显著更高(平均±标准差,110±32 vs 93±28 U/L;P≤0.001)。在对吸烟、高血压、肥胖、体力活动、教育程度和饮酒情况进行调整后,将oxLDL分布的上三分位数与下三分位数进行比较,未来发生冠心病事件的HR为4.25(95%置信区间,2.09至8.63;P<0.001)。与传统脂蛋白谱和其他冠心病传统危险因素相比,血浆oxLDL是冠心病事件最强的预测因子。当在同一模型中同时评估oxLDL和C反应蛋白时,即使经过多变量调整,它们仍能预测未来的冠心病事件。
oxLDL浓度升高可预测看似健康男性未来发生冠心病事件。因此,oxLDL可能是临床冠心病并发症的一个有前景的风险标志物,应在进一步研究中进行评估。